, Tracking Stock Market Picks
Enter Symbol:
Apricus Biosciences Inc (APRI) [hlAlert]

down 65.35 %

Apricus Biosciences Inc (APRI) rated Buy with price target $5.50 by Dawson James

Posted on: Tuesday,  Dec 14, 2010  8:25 AM ET by Dawson James

Dawson James rated Buy Apricus Biosciences Inc (NASDAQ: APRI) on 12/14/2010, when the stock price was $3.55. Since
then, Apricus Biosciences Inc has lost 65.35% as of 11/06/2015's recent price of $1.23.
If you would have followed this Dawson James's recommendation on APRI, you would have lost 65.35% of your investment in 1788 days.

NexMed, Inc. is a pharmaceutical and medical technology company. They develop and commercialize therapeutic products based on proprietary delivery systems. They are currently focusing their efforts on new and patented pharmaceutical products based on a penetration enhancement topical delivery technology known as NexACT(R), which may enable an active drug to be better absorbed through the skin.

Dawson James Securities is a full service investment firm with deep expertise in healthcare, biotechnology and technology with a staff of over 50 investment professionals ensures our clients stay ahead of the constant changes in the healthcare capital markets. From our widely-respected institutional research, investment banking and high net worth services to our personalized attention for individual accounts, we provide quality service for our clients. We take pride in the quality and depth of our professionals and encourage you to contact us so we can begin serving your financial needs today.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/14/2010 8:25 AM Buy
3.55 5.50
as of 12/31/2010
1 Week down  -1.01 %
1 Month up  12.68 %
3 Months   
1 YTD up  12.68 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy